Rhino C for common cold and influenza and symptomatic relief of rhinitis

 
4/5 ( 80% )
based on 1 ratings

Rhino C  Tablets

Composition :

Each tablet contains:
Paracetamol                              400mg
Phenylephrine Hcl                   5 mg
Ascorbic acid                            60 mg
Caffeine anhydrous                 35 mg

Properties :

Rtuno . C tablets is a unique drug for the treatment of common cold and influenza containing four synergistically acting agents:
– Paracetamol: As analgesic. antipyretic agent relieving symptoms of common cold as headache, chills, fever, and malaise
– Caffeine: Enhances analgesic effect of the product.
– Phenylephrine Hel : Sympathomimetic agent that relieves sinus I nasal congestion.
– Ascorbic acid ( vitamin C ) : As adjuvant natural component that prevents common cold or shortens its duration.

Indications & Usage :

– Common cold and influenza.
– Symptomatic relief of rhinitis ,sinusitis and upper respiratory allergies.

Contra-Indications :

– Hypersensitivity to any of the drug components.
– Cardiac disease.
– Glucoma , hyperthyroidism.

Side Effects :

Side effects are rare induding skin rash I headache, reflex bradycardia and anxiety may occur .

Drug Interactions :

– Phenylephrine Hel : May reduce the anlihypertensive effect of methyldopa. guanthidine and reserpine.
– MAO inhibitors and beta- adrenergic blockers may increase the effect of phenylephrine HCl.
– Paracetamol may enhance the anticoagulant effect of warfarin.
– Metodopramide and domperidone may accelerate the absorbance of paracetamol

Warnings & Precautions :

Used cautiously in elderly patients I renal or hepatic impairment.

Dosage & Administration :

( 1-2 ) lablels Iwo to three limes daily or as prescribed by the physician.

Packing :

Boxes of 20 tablets

Storage :

store bellow 3o c. and-R.H bellow 70%,away from light
Keep medicament out of children reach

Produced by :

chemical industries development (CID) GIZA – A.R.E

Be the first to comment

Leave a Reply

Your email address will not be published.


*